SCHEMBL1990147

SCHEMBL1990147

Cc1cc(C)nc(N(C)CCN(C)c2ccc(NC(=O)C(=O)c3c(-c4ccccc4)cc4n3CCOC4)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.39
HTT P42858 3/20 0.39
LMNA P02545 3/20 0.39
ALDH1A1 P00352 3/20 0.39
CASR P41180 1/20 0.36
CHRNA7 P36544 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPC1 O15118 2/20 0.33
TP53 P04637 2/20 0.33
RAB9A P51151 2/20 0.33
MCHR1 Q99705 4/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
PDGFRB P09619 1/20 0.32
KDR P35968 1/20 0.32
FLT3 P36888 1/20 0.32
HSD17B10 Q99714 3/20 0.32
POLB P06746 2/20 0.32
TDP1 Q9NUW8 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1988872 0.97 MAPT (0.38) MAPTHTTLMNAALDH1A1CASR
SCHEMBL1988743 0.92 MAPT (0.37) MAPTHTTLMNAALDH1A1CASR
SCHEMBL1126809 0.92 MAPT (0.38) MAPTHTTLMNAALDH1A1CASR
SCHEMBL1994847 0.90 PIK3CA (0.38) MAPTHTTLMNAALDH1A1CASR
SCHEMBL1989025 0.89 CASR (0.39) MAPTHTTLMNAALDH1A1CASR
SCHEMBL1989804 0.89 LMNA (0.35) MAPTHTTLMNAALDH1A1CASR
SCHEMBL942413 0.88 MCHR1 (0.34) MAPTHTTLMNAALDH1A1SMN1; SMN2
SCHEMBL1993577 0.86 SMN1; SMN2 (0.34) MAPTHTTLMNAALDH1A1SMN1; SMN2
SCHEMBL942871 0.85 HTT (0.34) MAPTHTTLMNAALDH1A1SMN1; SMN2
SCHEMBL1988907 0.82 LMNA (0.38) MAPTHTTLMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2626361-B1 Pyrrole antifungal agents F2G LTD (GB) 2014-10-15 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 MAPT 1696/4885HTT 776/4885LMNA 3641/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 MAPT 1696/4885HTT 776/4885LMNA 3641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.